These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21089722)

  • 1. Aminoterminal B-type natriuretic peptide (NT-proBNP) in the therapy of patent ductus arteriosus.
    Bagnoli F; Rossetti A; Casucci M; Mori A
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):67-70. PubMed ID: 21089722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
    Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
    Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
    Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
    Nuntnarumit P; Chongkongkiat P; Khositseth A
    Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus.
    Occhipinti F; De Carolis MP; De Rosa G; Bersani I; Lacerenza S; Cota F; Rubortone SA; Romagnoli C
    J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1800-4. PubMed ID: 24397409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes of brain-type natriuretic peptide in preterm neonates.
    da Graca RL; Hassinger DC; Flynn PA; Sison CP; Nesin M; Auld PA
    Pediatrics; 2006 Jun; 117(6):2183-9. PubMed ID: 16740863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
    Kulkarni M; Gokulakrishnan G; Price J; Fernandes CJ; Leeflang M; Pammi M
    Pediatrics; 2015 Feb; 135(2):e510-25. PubMed ID: 25601976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.
    Ramakrishnan S; Heung YM; Round J; Morris TP; Collinson P; Williams AF
    Acta Paediatr; 2009 Aug; 98(8):1254-9. PubMed ID: 19432837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated urinary NT-proBNP after pharmacological closure of patent ductus arteriosus in very low birth weight infants.
    Celik IH; Erdeve O; Demırel G; Canpolat FE; Dilmen U
    Early Hum Dev; 2013 Mar; 89(3):187-9. PubMed ID: 23084575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ligation of a persistent ductus arteriosus in an extremely premature infant].
    Schulze A; Gmyrek D; Schubert W; Roesner D; Schiffner H; Schnabel P
    Kinderarztl Prax; 1986 Jan; 54(1):9-20. PubMed ID: 3959403
    [No Abstract]   [Full Text] [Related]  

  • 12. Early NT-proBNP is able to predict spontaneous closure of patent ductus arteriosus in preterm neonates, but not the need of its treatment.
    Martinovici D; Vanden Eijnden S; Unger P; Najem B; Gulbis B; Maréchal Y
    Pediatr Cardiol; 2011 Oct; 32(7):953-7. PubMed ID: 21656237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus.
    Attridge JT; Kaufman DA; Lim DS
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F178-82. PubMed ID: 18981033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage.
    El-Khuffash A; Barry D; Walsh K; Davis PG; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F407-12. PubMed ID: 18285375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants.
    König K; Guy KJ; Drew SM; Barfield CP
    Acta Paediatr; 2015 Apr; 104(4):e139-42. PubMed ID: 25488470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
    Nuntnarumit P; Khositseth A; Thanomsingh P
    J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants.
    El-Khuffash AF; Slevin M; McNamara PJ; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F133-7. PubMed ID: 21071684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum brain natriuretic peptide for prediction of successful medical treatment of patent ductus arteriosus in premature infants.
    Ohashi A; Kaneko K
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):261-2. PubMed ID: 19577111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.